Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Financial managers' costing expertise is needed in clinical trials.

West DA, Balas EA, West TD.

J Health Care Finance. 2000 Fall;27(1):11-20.

PMID:
10961828
2.

Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.

Wilby J, Kainth A, Hawkins N, Epstein D, McIntosh H, McDaid C, Mason A, Golder S, O'Meara S, Sculpher M, Drummond M, Forbes C.

Health Technol Assess. 2005 Apr;9(15):1-157, iii-iv. Review.

3.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
4.

Product line cost estimation: a standard cost approach.

Cooper JC, Suver JD.

Healthc Financ Manage. 1988 Apr;42(4):60, 62, 64 passim.

PMID:
10286385
5.

Generalisability in economic evaluation studies in healthcare: a review and case studies.

Sculpher MJ, Pang FS, Manca A, Drummond MF, Golder S, Urdahl H, Davies LM, Eastwood A.

Health Technol Assess. 2004 Dec;8(49):iii-iv, 1-192. Review.

6.

Activity-based costing management in a private practice setting.

Carlomagno M, Draper V.

Med Group Manage J. 1997 May-Jun;44(3):68-70, 72, 78.

PMID:
10167631
7.

Three financial strategies.

West DA.

J Health Care Finance. 2003 Fall;30(1):10-22.

PMID:
12967240
8.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

9.

Procedures and methods of benefit assessments for medicines in Germany.

Bekkering GE, Kleijnen J.

Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5.

PMID:
18987905
10.

Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

Williams C, Brunskill S, Altman D, Briggs A, Campbell H, Clarke M, Glanville J, Gray A, Harris A, Johnston K, Lodge M.

Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. Review.

11.

Clinical and cost-effectiveness of new and emerging technologies for early localised prostate cancer: a systematic review.

Hummel S, Paisley S, Morgan A, Currie E, Brewer N.

Health Technol Assess. 2003;7(33):iii, ix-x, 1-157. Review.

12.

Clinical trials finance and operations.

O'Brien JA.

J Med Pract Manage. 2007 May-Jun;22(6):369-71.

PMID:
17612316
13.

The principles of quality-associated costing: derivation from clinical transfusion practice.

Trenchard PM, Dixon R.

Qual Manag Health Care. 1997 Summer;5(4):43-52.

PMID:
10169784
14.

Process-based costing.

Lee RH, Bott MJ, Forbes S, Redford L, Swagerty DL, Taunton RL.

J Nurs Care Qual. 2003 Oct-Dec;18(4):259-66.

PMID:
14556582
15.

The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation.

Hind D, Tappenden P, Tumur I, Eggington S, Sutcliffe P, Ryan A.

Health Technol Assess. 2008 May;12(15):iii-ix, xi-162. Review.

16.

Randomised clinical trial, observational study and assessment of cost-effectiveness of the treatment of varicose veins (REACTIV trial).

Michaels JA, Campbell WB, Brazier JE, Macintyre JB, Palfreyman SJ, Ratcliffe J, Rigby K.

Health Technol Assess. 2006 Apr;10(13):1-196, iii-iv. Review.

17.

Comparison of conference abstracts and presentations with full-text articles in the health technology assessments of rapidly evolving technologies.

Dundar Y, Dodd S, Dickson R, Walley T, Haycox A, Williamson PR.

Health Technol Assess. 2006 Feb;10(5):iii-iv, ix-145. Review.

18.

Interpreting cost analyses of clinical interventions.

Balas EA, Kretschmer RA, Gnann W, West DA, Boren SA, Centor RM, Nerlich M, Gupta M, West TD, Soderstrom NS.

JAMA. 1998 Jan 7;279(1):54-7. Review.

PMID:
9424045
19.

Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.

Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D; Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology; Technology Assessment Committee of the Society of Interventional Radiology.

Stroke. 2003 Aug;34(8):e109-37. Epub 2003 Jul 17. Erratum in: Stroke. 2003 Nov;34(11):2774.

20.

Applying activity-based costing to healthcare settings.

Canby JB 4th.

Healthc Financ Manage. 1995 Feb;49(2):50-2, 54-6.

PMID:
10146178
Items per page

Supplemental Content

Write to the Help Desk